ACCESS Newswire to Host Q4 2025 Results Conference Call
- Conference Call Details: ACCESS Newswire will host a conference call on March 19, 2026, at 9:00 AM Eastern Time to discuss its fourth quarter and full-year results for 2025, which is expected to provide investors with crucial financial insights and future outlook.
- Participation Instructions: Participants are advised to dial in 5 to 10 minutes before the call starts, using the numbers 973-528-0011 or 888-506-0062 with access code 780931, ensuring timely access to the latest company updates for investors.
- Replay Information: A replay of the call will be available approximately one hour after the event, accessible via 919-882-2331 or 877-481-4010 with passcode 52263, allowing investors who missed the live event to catch up on the information shared.
- Forward-Looking Statements: The company emphasizes its confidence in transitioning to a subscription model to drive sustainable growth, acknowledging potential risks and uncertainties while committing to initiatives aimed at enhancing performance and delivering improved results in the future.
Trade with 70% Backtested Accuracy
Analyst Views on ACCS
About ACCS
About the author
ACCESS Newswire to Host Q4 2025 Results Conference Call
- Conference Call Details: ACCESS Newswire will host a conference call on March 19, 2026, at 9:00 AM Eastern Time to discuss its fourth quarter and full-year results for 2025, which is expected to provide investors with crucial financial insights and future outlook.
- Participation Instructions: Participants are advised to dial in 5 to 10 minutes before the call starts, using the numbers 973-528-0011 or 888-506-0062 with access code 780931, ensuring timely access to the latest company updates for investors.
- Replay Information: A replay of the call will be available approximately one hour after the event, accessible via 919-882-2331 or 877-481-4010 with passcode 52263, allowing investors who missed the live event to catch up on the information shared.
- Forward-Looking Statements: The company emphasizes its confidence in transitioning to a subscription model to drive sustainable growth, acknowledging potential risks and uncertainties while committing to initiatives aimed at enhancing performance and delivering improved results in the future.
ACCESS Newswire Inc. (ACCS) Surpasses Q3 Earnings and Revenue Projections
Earnings Performance: ACCESS Newswire Inc. reported quarterly earnings of $0.20 per share, exceeding the Zacks Consensus Estimate of $0.15, marking a 33.33% earnings surprise. However, the company has only surpassed consensus EPS estimates once in the last four quarters.
Revenue Insights: The company generated revenues of $5.72 million for the quarter, slightly above the Zacks Consensus Estimate but down from $6.95 million a year ago. ACCESS has also topped revenue estimates just once in the past four quarters.
Stock Outlook: ACCESS Newswire's stock has underperformed the market with a 0.5% decline since the start of the year, compared to the S&P 500's 16.2% gain. The stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Industry Context: The Media Conglomerates industry, to which ACCESS belongs, is ranked in the bottom 39% of Zacks industries, suggesting potential challenges ahead. Investors are advised to monitor earnings estimate revisions and industry outlooks for better stock performance insights.
Earnings Report Ahead of Market Opening for November 11, 2025: SE, AU, PVLA, DAVA, BWAY, CRNT, PODC, ACCS, WKHS
Earnings Reports Overview: Several companies, including Sea Limited, AngloGold Ashanti, and Palvella Therapeutics, are set to report earnings on November 11, 2025, with varying forecasts indicating significant year-over-year growth for some.
Sea Limited Performance: Sea Limited is expected to report earnings per share of $0.75, reflecting a 212.50% increase from the previous year, with a Price to Earnings ratio of 54.92, indicating strong growth potential compared to industry peers.
AngloGold Ashanti and Brainsway: AngloGold Ashanti anticipates earnings of $1.34 per share (up 139.29%), while Brainsway forecasts $0.11 per share (up 175.00%), both suggesting higher growth than their respective industry averages.
Mixed Results for Other Companies: Companies like Ceragon Networks and Workhorse Group are expected to report lower earnings per share compared to last year, while PodcastOne and ACCESS Newswire show modest increases, highlighting a diverse earnings landscape.
ACCESS Newswire Reports Second Quarter 2025 Results
Operational Performance: ACCESS Newswire reported a 3% increase in revenue to $5.6 million for Q2 2025, alongside a significant rise in adjusted EBITDA to $836,000, reflecting improved operational efficiencies and a positive cash flow from operations of $135,000.
Subscription Growth: The company continues to transition to a subscription-based model, with the number of subscription customers increasing to 971, contributing to a gross margin of 76% and a return to mid-teen percentages of adjusted EBITDA relative to revenue.
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday
Analyst Ratings Updates: Barclays analyst Gena Wang initiated coverage on Cytokinetics, Inc. (CYTK) with an Overweight rating and a price target of $5, while Lake Street analyst Jacob Stephan gave ACCESS Newswire Inc. (ACCS) a Buy rating with a price target of $15.
Current Stock Performance: As of Wednesday, Cytokinetics shares closed at $38.00 and ACCESS Newswire shares at $8.65, reflecting significant differences from the analysts' price targets.
Lake Street Initiates Coverage On ACCESS Newswire with Buy Rating, Announces Price Target of $15
Real-time Intelligence: Benzinga Pro offers the fastest news alerts and real-time intelligence for traders to enhance their market performance.
Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, benefiting from exclusive stories and accurate stock market insights.
ACCESS Newswire to Host Q4 2025 Results Conference Call
- Conference Call Details: ACCESS Newswire will host a conference call on March 19, 2026, at 9:00 AM Eastern Time to discuss its fourth quarter and full-year results for 2025, which is expected to provide investors with crucial financial insights and future outlook.
- Participation Instructions: Participants are advised to dial in 5 to 10 minutes before the call starts, using the numbers 973-528-0011 or 888-506-0062 with access code 780931, ensuring timely access to the latest company updates for investors.
- Replay Information: A replay of the call will be available approximately one hour after the event, accessible via 919-882-2331 or 877-481-4010 with passcode 52263, allowing investors who missed the live event to catch up on the information shared.
- Forward-Looking Statements: The company emphasizes its confidence in transitioning to a subscription model to drive sustainable growth, acknowledging potential risks and uncertainties while committing to initiatives aimed at enhancing performance and delivering improved results in the future.
ACCESS Newswire Inc. (ACCS) Surpasses Q3 Earnings and Revenue Projections
Earnings Performance: ACCESS Newswire Inc. reported quarterly earnings of $0.20 per share, exceeding the Zacks Consensus Estimate of $0.15, marking a 33.33% earnings surprise. However, the company has only surpassed consensus EPS estimates once in the last four quarters.
Revenue Insights: The company generated revenues of $5.72 million for the quarter, slightly above the Zacks Consensus Estimate but down from $6.95 million a year ago. ACCESS has also topped revenue estimates just once in the past four quarters.
Stock Outlook: ACCESS Newswire's stock has underperformed the market with a 0.5% decline since the start of the year, compared to the S&P 500's 16.2% gain. The stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Industry Context: The Media Conglomerates industry, to which ACCESS belongs, is ranked in the bottom 39% of Zacks industries, suggesting potential challenges ahead. Investors are advised to monitor earnings estimate revisions and industry outlooks for better stock performance insights.
Earnings Report Ahead of Market Opening for November 11, 2025: SE, AU, PVLA, DAVA, BWAY, CRNT, PODC, ACCS, WKHS
Earnings Reports Overview: Several companies, including Sea Limited, AngloGold Ashanti, and Palvella Therapeutics, are set to report earnings on November 11, 2025, with varying forecasts indicating significant year-over-year growth for some.
Sea Limited Performance: Sea Limited is expected to report earnings per share of $0.75, reflecting a 212.50% increase from the previous year, with a Price to Earnings ratio of 54.92, indicating strong growth potential compared to industry peers.
AngloGold Ashanti and Brainsway: AngloGold Ashanti anticipates earnings of $1.34 per share (up 139.29%), while Brainsway forecasts $0.11 per share (up 175.00%), both suggesting higher growth than their respective industry averages.
Mixed Results for Other Companies: Companies like Ceragon Networks and Workhorse Group are expected to report lower earnings per share compared to last year, while PodcastOne and ACCESS Newswire show modest increases, highlighting a diverse earnings landscape.
ACCESS Newswire Reports Second Quarter 2025 Results
Operational Performance: ACCESS Newswire reported a 3% increase in revenue to $5.6 million for Q2 2025, alongside a significant rise in adjusted EBITDA to $836,000, reflecting improved operational efficiencies and a positive cash flow from operations of $135,000.
Subscription Growth: The company continues to transition to a subscription-based model, with the number of subscription customers increasing to 971, contributing to a gross margin of 76% and a return to mid-teen percentages of adjusted EBITDA relative to revenue.
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday
Analyst Ratings Updates: Barclays analyst Gena Wang initiated coverage on Cytokinetics, Inc. (CYTK) with an Overweight rating and a price target of $5, while Lake Street analyst Jacob Stephan gave ACCESS Newswire Inc. (ACCS) a Buy rating with a price target of $15.
Current Stock Performance: As of Wednesday, Cytokinetics shares closed at $38.00 and ACCESS Newswire shares at $8.65, reflecting significant differences from the analysts' price targets.
Lake Street Initiates Coverage On ACCESS Newswire with Buy Rating, Announces Price Target of $15
Real-time Intelligence: Benzinga Pro offers the fastest news alerts and real-time intelligence for traders to enhance their market performance.
Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, benefiting from exclusive stories and accurate stock market insights.
